Evidence map›Paper›PMID 33509870›Full record

ArticleBMJ case reports2021

Recurrent disseminated

Kristen Zeitler, Jolan Walter, Fatima Khan, Chakrapol Sriaroon

Open access · greenAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ case reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Kristen ZeitlerPharmacy, Tampa General Hospital, Tampa, Florida, USA.
Jolan WalterPediatric Allergy/Immunology, University of South Florida College of Medicine, Tampa, Florida, USA.
Fatima KhanPediatric Allergy/Immunology, University of South Florida College of Medicine, Tampa, Florida, USA.
Chakrapol SriaroonPulmonary/Critical Care, University of South Florida College of Medicine, Tampa, Florida, USA csriaro@health.usf.edu.
University of South Florida · USFlorida College · USTampa General Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anti-interferon-gamma (IFN-γ) autoantibodies has been recognised as an adult-onset immunodeficiency in the past decade in people who originate from Southeast Asia. These patients are susceptible to particular opportunistic infections, especially non-tuberculous mycobacteria (NTM). We present the case of a woman whom originally came from Thailand with disseminated

Indexed as

AdultAnti-Bacterial AgentsAsian PeopleAutoantibodiesAzithromycinBacteremiaDisease ProgressionEthambutolFemaleHumansImmunologic Deficiency SyndromesImmunologic FactorsInterferon-gammaMycobacterium avium ComplexMycobacterium avium-intracellulare InfectionPericarditisAnti-Bacterial AgentsAutoantibodiesAzithromycinEthambutolImmunologic FactorsInterferon-gammaRifampinRituximabimmunologyinfectious diseases

Identifiers

PMID33509870
PMCPMC7845683
OpenAlexW3125502627

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.